Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Eton Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ETON
Nasdaq
2834
www.etonpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Eton Pharmaceuticals, Inc.
Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline
- May 7th, 2025 2:00 pm
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
- May 1st, 2025 8:30 pm
Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release
- May 1st, 2025 2:01 pm
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
- Apr 28th, 2025 10:50 am
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability
- Apr 15th, 2025 1:07 pm
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
- Apr 1st, 2025 11:00 am
Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
- Mar 19th, 2025 10:50 am
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates
- Mar 18th, 2025 12:00 pm
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
- Mar 18th, 2025 10:50 am
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
- Mar 14th, 2025 10:50 am
Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?
- Mar 6th, 2025 2:40 pm
Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025
- Mar 4th, 2025 11:50 am
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
- Mar 3rd, 2025 11:50 am
Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?
- Feb 20th, 2025 2:57 pm
Eton secures US patent for diabetes insipidus treatment
- Feb 10th, 2025 12:11 pm
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
- Feb 7th, 2025 11:50 am
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
- Feb 6th, 2025 11:50 am
New Strong Buy Stocks for January 28th
- Jan 28th, 2025 11:20 am
Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum
- Jan 25th, 2025 2:15 pm
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?
- Jan 24th, 2025 9:17 am
Scroll